Franklin Resources Inc Amgen Inc Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Amgen Inc stock. As of the latest transaction made, Franklin Resources Inc holds 2,079,293 shares of AMGN stock, worth $664 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,079,293

Previous 1,690,328 23.01%

Holding current value

$664 Million

Previous $481 Million 35.18%

% of portfolio

0.21%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $102 Million - $124 Million	388,965 Added 23.01%	2,079,293 $650 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $17.5 Million - $21.1 Million	65,118 Added 4.01%	1,690,328 $481 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $41.7 Million - $47 Million	-163,004 Reduced 9.12%	1,625,210 $468 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $329 Million - $408 Million	-1,502,712 Reduced 45.66%	1,788,214 $481 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $237 Million - $280 Million	1,106,980 Added 50.69%	3,290,926 $731 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $157 Million - $192 Million	697,076 Added 46.88%	2,183,946 $528 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $199 Million - $253 Million	-870,210 Reduced 36.92%	1,486,870 $391 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $196 Million - $221 Million	-872,941 Reduced 27.03%	2,357,080 $531 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $117 Million - $131 Million	-508,679 Reduced 13.61%	3,230,021 $786 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $4.45 Million - $4.93 Million	-20,306 Reduced 0.54%	3,738,700 $904 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $40 Million - $45.7 Million	-200,879 Reduced 5.07%	3,759,006 $846 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $114 Million - $134 Million	539,342 Added 15.77%	3,959,885 $842 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $109 Million - $121 Million	465,676 Added 15.76%	3,420,543 $834 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $243 Million - $283 Million	1,096,236 Added 58.98%	2,954,867 $735 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $2.38 Million - $2.83 Million	-10,986 Reduced 0.59%	1,858,631 $427 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $35 Million - $38.9 Million	-149,124 Reduced 7.39%	1,869,617 $475 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $7.7 Million - $9.45 Million	38,912 Added 1.97%	2,018,741 $519 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $11.3 Million - $15 Million	-61,921 Reduced 3.03%	1,979,829 $401 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $50 Million - $64.2 Million	-264,143 Reduced 11.46%	2,041,750 $492 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $24.5 Million - $29.3 Million	-140,525 Reduced 5.74%	2,305,893 $446 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $187 Million - $219 Million	-1,120,931 Reduced 31.42%	2,446,418 $451 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $28.6 Million - $32.3 Million	-158,347 Reduced 4.25%	3,567,349 $678 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $4.47 Million - $5.22 Million	-25,053 Reduced 0.67%	3,725,696 $725 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $37.4 Million - $42.1 Million	-201,628 Reduced 5.1%	3,750,749 $778 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $16.1 Million - $18.1 Million	-96,968 Reduced 2.39%	3,952,377 $730 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $486 Million - $568 Million	-2,869,828 Reduced 41.48%	4,049,345 $690 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $8.56 Million - $9.57 Million	-50,723 Reduced 0.73%	6,919,173 $1.2 Billion
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.17 Billion - $1.33 Billion	6,969,896	6,969,896 $1.3 Billion

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

417M

Call Options Held

7.18M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Amgen Inc Transaction History